Skip to search formSkip to main contentSkip to account menu

AM 1155

Known as: AM-1155 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

gatifloxacin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
In Vitro Antibacterial Activity of AM-1155 against MRSA
AM-1155 (fig. 1) is a new fluoroquinolone developed by Kyorin Pharmaceuticals. It is characterised by the presence of a… 
1999
1999
In Vitro Antibacterial Activities of Gatifloxacin (AM-1155) Against Clinical Pathogens Recently Isolated from Various Infections
Gatifloxacin (AM-1155), a newly developed 6fluoro-8-methoxy quinolone, shows a potent activity against Gram-positive andGram… 
1999
1999
Complex Mycobacterium avium and tuberculosis Mycobacterium Levofloxacin against ( DU-6859 a ) , Gatifloxacin ( AM-1155 ) , and Quinolone HSR-903 , Sitafloxacin Activities of the Newly Synthesized…
1998
1998
Brief reports Antibacterial activity of AM-1155 against penicillin-resistant Streptococcus pneumoniae
AM-1155, a novel fluoroquinolone, exhibited potent activity against Streptococcus pneumoniae, including penicillin-resistant… 
1997
1997
Original articles Comparative in-vitro and in-vivo activity of AM-1155 against anaerobic bacteria
The in-vitro activity of AM-1155, a 6-fluoro-8-methoxy quinolone, was compared with those of temafloxacin, sparfloxacin… 
1995
1995
ラット慢性気道感染症モデルにおける6-Fluoro-8-Methoxy Quinolone (AM-1155) の効果の検討
1995
1995
Tapping into the fluoroquinolone pipeline
&The development of novel fluoroquinolones continues to be a popular approach to meeting the need for new antibacterial agents… 
1995
1995
ラット慢性気道感染症モデルにおける 6-Fluoro-8-Methoxy Quinolone (AM-1155) の効果の検討 : 気管支随伴リンパ組織(BALT)の過形成に及ぼす影響
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)